Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 entities : Takeda pharmaceutical company limited save search
COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.11%
H: 0.33%
C: -0.98%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: -0.33%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.44%
H: 0.22%
C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.55%
H: 0.3%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
covid-19
Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.13%
H: 0.0%
C: -0.23%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.13%
H: 0.71%
C: 0.65%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.14%
H: 0.28%
C: -0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
covid-19 drug research global disease report impact gastrointestinal market
Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 japan vaccine authorization
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
Published: 2022-05-31 (Crawled : 09:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -2.24%
H: 0.35%
C: -0.14%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 5.09%
H: 0.0%
C: 0.0%
covid-19 japan vaccine authorization
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
Published: 2022-04-20 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.17%
H: 0.68%
C: 0.27%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.06%
H: 1.14%
C: 0.91%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: -20.04%
H: 28.04%
C: 21.44%
covid-19 arct-154 vaccine mrna phase 3
Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published: 2022-04-19 (Crawled : 06:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: 0.0%
covid-19 nuvaxovid vaccine approval
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published: 2021-12-16 (Crawled : 05:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 5.55%
H: 0.0%
C: 0.0%
covid-19 new drug application drug approval covid vaccine submission
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
Published: 2021-05-21 (Crawled : 09:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.75%
H: 0.63%
C: -0.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
covid vaccine approval covid-19
Global Medical Enzyme Technology Market (2021 to 2028) - COVID-19 Impact and Analysis
Published: 2021-05-19 (Crawled : 18:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.6%
H: 1.38%
C: 1.12%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.52%
H: 0.35%
C: -0.06%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -0.89%
H: 2.1%
C: 2.05%
covid technology covid-19
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Published: 2021-03-15 (Crawled : 13:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.36%
H: 1.12%
C: 0.96%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.09%
H: 0.57%
C: 0.42%
covid vaccine covid-19
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.